SCOPUS 정보 검색 플랫폼

New England Journal of Medicine

Volumn 357, Issue 13, 2007, Pages 1347-1348

Anidulafungin and fluconazole for candidiasis [2]

(2) Nir Paz, Ran a Moses, Allon E b

a UNIVERSITY OF CALIFORNIA (United States)

b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANIDULAFUNGIN; ANTIFUNGAL AGENT; FLUCONAZOLE; CYCLOPEPTIDE;

CANDIDIASIS; CATHETER REMOVAL; CLINICAL ARTICLE; CLINICAL TRIAL; HUMAN; INVASIVE CANDIDIASIS; LETTER; PRIORITY JOURNAL; TREATMENT FAILURE; TREATMENT OUTCOME; ANALYSIS OF VARIANCE; CENTRAL VENOUS CATHETERIZATION; INTRAVENOUS DRUG ADMINISTRATION; NOTE; ORAL DRUG ADMINISTRATION; TIME;

ADMINISTRATION, ORAL; ANALYSIS OF VARIANCE; ANTIFUNGAL AGENTS; CANDIDIASIS; CATHETERIZATION, CENTRAL VENOUS; FLUCONAZOLE; HUMANS; INFUSIONS, INTRAVENOUS; PEPTIDES, CYCLIC; TIME FACTORS;

EID: 34748912907 PISSN: 00284793 EISSN: 15334406 Source Type: Journal
DOI: 10.1056/NEJMc071981 Document Type: Letter

Times cited : (4)

References (8)

1
- 34250341787
- Anidulafungin versus fluconazole for invasive candidiasis.
- AC Reboli C Rotstein RG Pappas Anidulafungin versus fluconazole for invasive candidiasis. N Engl J Med 356 2007 2472 2482
- (2007) N Engl J Med , vol.356 , pp. 2472-2482
- Reboli, AC¹ Rotstein, C² Pappas, RG³

2
- 33644789375
- Quality of reporting of noninferiority and equivalence randomized trials.
- A Le Henanff B Giraudeau G Baron P Ravaud Quality of reporting of noninferiority and equivalence randomized trials. JAMA 295 2006 1147 1151
- (2006) JAMA , vol.295 , pp. 1147-1151
- Le Henanff, A¹ Giraudeau, B² Baron, G³ Ravaud, P⁴

3
- 0037165269
- Voriconazole versus liposomal amphotericin B in patients with neutropenia and persistent fever.
- JH Powers CA Dixon MJ Goldberger Voriconazole versus liposomal amphotericin B in patients with neutropenia and persistent fever. N Engl J Med 346 2002 289 290
- (2002) N Engl J Med , vol.346 , pp. 289-290
- Powers, JH¹ Dixon, CA² Goldberger, MJ³

4
- 0742299199
- Guidelines for treatment of candidiasis.
- PG Pappas JH Rex JD Sobel Guidelines for treatment of candidiasis. Clin Infect Dis 38 2004 161 189
- (2004) Clin Infect Dis , vol.38 , pp. 161-189
- Pappas, PG¹ Rex, JH² Sobel, JD³

5
- 0037468689
- Caspofungin versus amphotericin B for invasive candidiasis.
- AL Brown JR Greig NA Kartsonis J Perfect TJ Walsh Caspofungin versus amphotericin B for invasive candidiasis. N Engl J Med 348 2003 1287 1288
- (2003) N Engl J Med , vol.348 , pp. 1287-1288
- Brown, AL¹ Greig, JR² Kartsonis, NA³ Perfect, J⁴ Walsh, TJ⁵

6
- 85120204605
- Piaggio G, Elbourne DR, Altman DG, Pocock SJ, Evans SJW. Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. JAMA 2006;295:1152- 60. [Erratum, JAMA 2006;296:1842.]

7
- 0742299199
- Guidelines for treatment of candidiasis.
- PG Pappas JH Rex JD Sobel Guidelines for treatment of candidiasis. Clin Infect Dis 38 2004 161 189
- (2004) Clin Infect Dis , vol.38 , pp. 161-189
- Pappas, PG¹ Rex, JH² Sobel, JD³

8
- 0037508540
- A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects.
- JH Rex PG Pappas AW Karchmer A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects. Clin Infect Dis 36 2003 1221 1228
- (2003) Clin Infect Dis , vol.36 , pp. 1221-1228
- Rex, JH¹ Pappas, PG² Karchmer, AW³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.